Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-23

Clinical Trial Update: EUpertstrain 4 Study of Bordetella Pertussis Isolates

View source ↗

Summary

The EUpertstrain 4 study investigating Bordetella pertussis isolates has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Turku | Conditions: Bordetella Pertussis, Whooping Cough | Status: COMPLETED